BRIEF published on 11/10/2025 at 18:10, 8 months 16 days ago Ascend's Innovation Enhances AAV Production Efficiency Gene Therapy Biotechnology Innovation Ascend Advanced Therapies AAV Production Manufacturing Enhancers
BRIEF published on 11/10/2025 at 18:10, 8 months 16 days ago L'innovation d'Ascend améliore l'efficacité de la production d'AAV Thérapie Génique Innovation En Biotechnologie Ascend Advanced Therapies Production AAV Améliorants De Fabrication
PRESS RELEASE published on 11/10/2025 at 18:05, 8 months 16 days ago Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality Ascend Advanced Therapies unveils proprietary enhancers demonstrating significant improvements in AAV yields and quality attributes for gene therapy programs Ascend Advanced Therapies Proprietary Enhancers AAV Yields Gene Therapy Programs Quality Attributes
BRIEF published on 10/08/2025 at 15:10, 9 months 18 days ago Ascend Advanced Therapies Successfully Defends EpyQ® Patent at EPO Intellectual Property Gene Therapy European Patent Office Ascend Advanced Therapies EpyQ® AAV Plasmid
BRIEF published on 10/08/2025 at 15:10, 9 months 18 days ago Ascend Advanced Therapies défend avec succès le brevet EpyQ® auprès de l'OEB Propriété Intellectuelle Thérapie Génique Office Européen Des Brevets Thérapies Avancées Ascend Plasmide AAV EpyQ®
PRESS RELEASE published on 10/08/2025 at 15:05, 9 months 18 days ago European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO Ascend Advanced Therapies successfully defends European patent EP3722434 for EpyQ® AAV plasmid technology at the EPO, reinforcing its position in gene therapy Gene Therapy European Patent Ascend Advanced Therapies EpyQ® AAV Plasmid Technology
Published on 07/25/2026 at 00:35, 1 day 17 hours ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 1 day 19 hours ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 20 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 20 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 22 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 1 day 23 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:15, 2 days ago EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Published on 07/24/2026 at 17:50, 2 days ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 18:50, 1 day 23 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 1 day 23 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 2 days ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
